ArticleMaterials today. Bio2025

Cholesterol modified defense peptide as an EMP2-siRNA delivery system for synergistic immunogene therapy against breast cancer.

Xiaoyun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.